EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Effect of short-term, high-dose probiotic supplementation on cognition, related brain functions and BDNF in patients with depression: a secondary analysis of a randomized controlled trial

Else Schneider, Jessica P K Doll, Nina Schweinfurth, Cedric Kettelhack, Anna-Chiara Schaub, Gulnara Yamanbaeva, Nimmy Varghese, Laura Mählmann, Serge Brand, Anne Eckert, Stefan Borgwardt, Undine E Lang und 1 weitere

Journal of Psychiatry and Neuroscience · 21.02.2023 · 48 (1) · E23-E33

DOI: 10.1503/jpn.220117 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Psychiatry and Neuroscience, erschienen am 21.02.2023. Verfasst von Else Schneider und 12 weiteren Autor:innen. Beteiligte Einrichtung: From the University of Basel, Department of Psychiatry (UPK), Basel, Switzerland (Schneider, Doll, Schweinfurth, Kettelhack, Schaub, Yamanbaeva, Varg…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Probiotics. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In major depressive disorder (MDD), cognitive dysfunctions strongly contribute to functional impairments but are barely addressed in current therapies. Novel treatment strategies addressing cognitive symptoms in depression are needed. As the gut microbiota–brain axis is linked to depression and cognition, we investigated the effect of a 4-week high-dose probiotic supplementation on cognitive symptoms in depression.

Methods

This randomized controlled trial included 60 patients with MDD, of whom 43 entered modified intention-to-treat analysis. A probiotic supplement or indistinguishable placebo containing maltose was administered over 31 days in addition to treatment as usual for depression. Participant scores on the Verbal Learning Memory Test (VLMT), Corsi Block Tapping Test, and both Trail Making Test versions as well as brain-derived neurotrophic factor levels were assessed at 3 different time points: before, immediately after and 4 weeks after intervention. Additionally, brain activation changes during working memory processing were investigated before and immediately after intervention.

Results

We found a significantly improved immediate recall in the VLMT in the probiotic group immediately after intervention, and a trend for a time × group interaction considering all time points. Furthermore, we found a time × group interaction in hippocampus activation during working memory processing, revealing a remediated hippocampus function in the probiotic group. Other measures did not reveal significant changes.

Limitations

The modest sample size resulting from our exclusion of low-compliant cases should be considered.

Conclusion

Additional probiotic supplementation enhances verbal episodic memory and affects neural mechanisms underlying impaired cognition in MDD. The present findings support the importance of the gut microbiota–brain axis in MDD and emphasize the potential of microbiota-related regimens to treat cognitive symptoms in depression. Clinical trial registration: clinicaltrials.gov identifier NCT02957591.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderProbioticsHumansBrain-Derived Neurotrophic FactorDepressionCognitionDietary SupplementsBrain

Substanzen

Brain-Derived Neurotrophic Factor

Autor:innen und Institutionen

  • From the University of Basel, Department of Psychiatry (UPK), Basel, Switzerland (Schneider, Doll, Schweinfurth, Kettelhack, Schaub, Yamanbaeva, Varghese, Mählmann, Brand, Eckert, Borgwardt, Lang, Schmidt); the Transfac…

Zitieren

APA

Schneider, E., Doll, J. P. K., Schweinfurth, N., Kettelhack, C., Schaub, A. C., Yamanbaeva, G., Varghese, N., Mählmann, L., Brand, S., Eckert, A., Borgwardt, S., Lang, U. E., & Schmidt, A. (2023). Effect of short-term, high-dose probiotic supplementation on cognition, related brain functions and BDNF in patients with depression: a secondary analysis of a randomized controlled trial. Journal of Psychiatry and Neuroscience, 48(1), E23-E33. https://doi.org/10.1503/jpn.220117

Vancouver

Schneider E, Doll JPK, Schweinfurth N, Kettelhack C, Schaub AC, Yamanbaeva G, et al. Effect of short-term, high-dose probiotic supplementation on cognition, related brain functions and BDNF in patients with depression: a secondary analysis of a randomized controlled trial. Journal of Psychiatry and Neuroscience. 2023;48(1):E23-E33. doi:10.1503/jpn.220117

BibTeX
@article{Schneider2023,
  author = {Schneider, Else and Doll, Jessica P K and Schweinfurth, Nina and Kettelhack, Cedric and Schaub, Anna-Chiara and Yamanbaeva, Gulnara and Varghese, Nimmy and Mählmann, Laura and Brand, Serge and Eckert, Anne and Borgwardt, Stefan and Lang, Undine E and Schmidt, André},
  title = {Effect of short-term, high-dose probiotic supplementation on cognition, related brain functions and BDNF in patients with depression: a secondary analysis of a randomized controlled trial},
  journal = {Journal of Psychiatry and Neuroscience},
  year = {2023},
  volume = {48},
  number = {1},
  pages = {E23--E33},
  doi = {10.1503/jpn.220117}
}
Kostenlos starten →